Deutsch English Français

Contact

EP1613365

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1613365

EP1613365 - EMBOLIC OCCLUSION OF UTERINE ARTERIES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 27.03.2009 Database last updated on 16.09.2024
Most recent event Tooltip	19.06.2009	Change - representative	published on 22.07.2009 [2009/30]
Applicant(s)	For all designated states Vascular Control Systems, Inc. 32236-F Paseo Adelanto San Juan Capistrano, CA 92675 / US
	[N/P]
Former [2006/02]	For all designated states Vascular Control Systems, Inc. 32236-E Paseo Adelanto San Juan Capistrano, CA 92675 / US
Inventor(s)	01 / BURBANK, Fred, H. 12 Old Ranch Road Laguna Niguel, CA 92677 / US
	02 / ALTIERI, Greig 1102 Temple Hills Drive Laguna Beach, CA 92651 / US
	03 / JONES, Michael, L. 6332 Camino Marinero San Clemente, CA 92673 / US
	[2006/02]
Representative(s)	Barz, Peter Meissner Bolte & Partner GbR Postfach 86 06 24 81633 München / DE
	[N/P]
Former [2009/30]	Barz, Peter Patentanwalt Kaiserplatz 2 80803 München / DE
Former [2006/02]	Barz, Peter Patentanwalt Kaiserplatz 2 80803 München / DE
Application number, filing date	04759154.0	04.04.2004
	[2006/02]
	WO2004US10525
Priority number, date	US20030411690	11.04.2003 Original published format: US 411690
	[2006/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2004091683
	Date:	28.10.2004
	Language:	EN
	[2004/44]
	Type:	A2 Application without search report
	No.:	EP1613365
	Date:	11.01.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.10.2004 takes the place of the publication of the European patent application.
	[2006/02]
Search report(s)	International search report - published on:	EP	06.05.2005
Classification	IPC:	A61L31/06	[2006/02]
	CPC:	A61L24/046 (EP,US); A61P15/00 (EP); A61L2430/36 (EP,US)
	C-Set:	A61L24/046, C08L67/04 (EP,US); A61L24/046, C08L71/02 (US,EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/02]
Extension states	AL	Not yet paid
	HR	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	EMBOLIEVERSCHLUSS VON GEBÄRMUTTERARTERIEN	[2006/02]
	English:	EMBOLIC OCCLUSION OF UTERINE ARTERIES	[2006/02]
	French:	OCCLUSION EMBOLIQUE D'ARTERES UTERINES	[2006/02]
Entry into regional phase	07.10.2005	National basic fee paid
	07.10.2005	Designation fee(s) paid
	07.10.2005	Examination fee paid
Examination procedure	09.11.2004	Request for preliminary examination filed International Preliminary Examining Authority: US
	07.10.2005	Amendment by applicant (claims and/or description)
	07.10.2005	Examination requested [2006/02]
	04.09.2006	Despatch of a communication from the examining division (Time limit: M06)
	14.03.2007	Reply to a communication from the examining division
	08.05.2007	Despatch of a communication from the examining division (Time limit: M06)
	19.11.2007	Reply to a communication from the examining division
	24.04.2008	Despatch of a communication from the examining division (Time limit: M06)
	05.11.2008	Application deemed to be withdrawn, date of legal effect [2009/18]
	12.12.2008	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/18]
Fees paid	Renewal fee
	28.04.2006	Renewal fee patent year 03
	12.04.2007	Renewal fee patent year 04
	28.03.2008	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO0168720 (BIOCURE INC [US], et al) [X] 1,2 * page 4, lines 2-26 * * page 13, line 15 - page 16, line 6 * * page 20, lines 20-33 * * page 24, lines 15,16 * * table 3 *;
		[Y]WO0200192 (CARBON MEDICAL TECHNOLOGIES IN [US]) [Y] 1-7 * page 3, lines 15-20 *;
		[Y]WO0180713 (HYSTERX INC [US], et al) [Y] 1-7 * page 11, lines 20-25 * * page 15, lines 9-17 *;
		[X]WO9922774 (MICRO THERAPEUTICS INC [US], et al) [X] 8-52 * claims 1,2,8,9 *;
		[X]WO0071064 (MICRO THERAPEUTICS INC [US], et al) [X] 8-52 * page 9, line 27 - page 10, line 13 * * page 12, lines 15-20 * * page 13, line 22 - page 14, line 2 *;
		[Y]WO0001342 (MICRO THERAPEUTICS INC [US], et al) [Y] 8-31,37-52 * page 6, lines 10-20 * * page 7, lines 22-29 * * page 9, lines 10-19 *;
		[Y]WO9943366 (MICRO THERAPEUTICS INC [US], et al) [Y] 8-31,37-52 * page 5, lines 15-18 * * page 7, line 22 - page 8, line 4 * * page 10, lines 12-21 *;
		[X]US2002090398 (DUNN RICHARD L [US], et al) [X] 32-36 * paragraph [0016] * * paragraph [0024] * * paragraph [0031]; claims 1-9 *;
		[X]US4938763 (DUNN RICHARD L [US], et al) [X] 32-36 * column 2, lines 51-59 * * column 4, lines 44-68 * * column 5, lines 1-19 * * column 6, lines 9-30 *;
		[X]WO0024374 (ATRIX LAB INC [US], et al) [X] 32-36 * page 2, lines 14-29 * * page 5, lines 10-21 * * page 7, lines 10-26 *;
		[X]EP1266664 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [X] 32-36 * paragraphs [0009] , [0015] , [0018] *;
		[X]WO0249573 (BHAGWATWAR HARSHAL PRABHAKAR [IN], et al) [X] 32-36 * page 8, lines 20-31 * * page 10, line 19 - page 11, line 4 * * page 13, lines 4-29 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p